Clinical trials
Placebo - Control clinical trials
Below are recruiting placebo - control clinical trials, each written for real people, not researchers. We’re tracking 3,948 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07581470Recruiting
Steroid Injection to Reduce Pain After Hip Replacement Surgery
This study tests whether adding a steroid medication (dexamethasone) through an IV line during hip replacement surgery reduces pain afterward. Researchers will compare three different doses to see which works best when combined with a nerve block (numbing medicine injected near the hip).
PoznanAges 18–100 - NCT07346742Recruiting
Preventing infection in children's groin surgery
This study tests whether giving antibiotics through a vein and using special stitches that fight germs can help prevent infections after open groin surgery in children. It may be helpful for children having routine groin surgery as a day procedure.
Ile-Ife, Osun StateAges Up to 15 years - NCT07347743Recruiting
Probiotic supplement for crying and colic in healthy newborns
This trial tests whether a daily probiotic supplement can reduce excessive crying and colic in healthy, full-term newborns. If your baby is healthy and born at UZ Brussel, this study may help find a gentle way to soothe colic.
Jette, Brussels CapitalAges 1 day–2 weeks - NCT07348627RecruitingPhase 3
Opioid-free hip replacement study
This trial tests if using fewer opioids after hip replacement surgery can still control pain well. It uses a specific type of hip replacement called anterior total hip arthroplasty and aims to help patients recover with less reliance on strong pain medicines.
Atlanta, GeorgiaAges 18 years+ - NCT07349303RecruitingPhase 2
Pembrolizumab Before Surgery for Stage IIb/c Melanoma
This trial tests whether giving pembrolizumab (Keytruda) before surgery helps people with a certain type of advanced melanoma (stage IIb/c). The goal is to see if this treatment can improve outcomes before the tumor is removed.
GothenburgAges 18 years+ - NCT07349524RecruitingPhase 2
A study of an oral tablet for COPD
This study tests an oral tablet called RSS0343 for people with moderate to severe COPD. It aims to see if the tablet can improve lung function and reduce flare-ups when added to your current breathing treatments.
Guangzhou, GuangdongAges 40–80 - NCT07352423RecruitingPhase 1
Safety study of ALXN2230 in healthy volunteers
This trial tests the safety and how the body handles a new drug called ALXN2230 in healthy people. It helps find the right dose and checks for side effects.
LondonAges 18–65 - NCT07353671RecruitingPhase 2/Phase 3
Cockroach extract liquid for radiation skin damage
This trial tests a liquid made from cockroach extract (Meilian Fuxin) to prevent or treat skin damage from radiation therapy in people with head and neck cancer. It aims to see if this topical treatment can reduce radiation dermatitis compared to standard care.
Chengdu, SichuanAges 18–80 - NCT07354932RecruitingPhase 2
Testing SHR-2173 for IgA Nephropathy
This trial tests a new drug, SHR-2173, for people with IgA nephropathy who still have a lot of protein in their urine despite standard care. The goal is to see if it can help protect kidney function.
Guangzhou, GuangdongAges 18 years+ - NCT07359482RecruitingPhase 3
Fluvoxamine for fatigue after covid-19
This study tests the antidepressant fluvoxamine to see if it can reduce long-term fatigue in adults who developed severe tiredness after a covid-19 infection. You may join if your fatigue started or got worse after covid and has lasted at least 3 months.
Amsterdam-ZuidoostAges 18–70 - NCT07359534Recruiting
Training recovery with Levagen+ for cyclists and triathletes
This study tests if a supplement called Levagen+ helps trained cyclists and triathletes recover better after hard training. It's looking for healthy active adults who ride at a strong level.
LondonAges 18–50 - NCT07361692Recruiting
Electric brain stimulation for complex regional pain syndrome
This trial tests if a gentle electric current applied to the scalp (called tDCS) can reduce pain in people with Complex Regional Pain Syndrome (CRPS), a chronic pain condition. It aims to see if this treatment is effective and safe for managing symptoms.
Saint-NazaireAges 18 years+ - NCT07363460RecruitingPhase 2
HSK39297 tablets for active lupus nephritis
This study tests a new drug called HSK39297 combined with standard treatments (steroids and mycophenolate mofetil) for people with active lupus nephritis. It aims to see if the combination is safe and effective in reducing kidney inflammation.
Nanjing, JiangsuAges 18–75 - NCT07363395RecruitingPhase 1
A study of ASCT-83 in healthy adults
This trial tests a new medication called ASCT-83 in healthy adults to see how safe it is and how the body processes it. It may help researchers understand the right dose for future studies.
Saint Paul, MinnesotaAges 18–64 - NCT07363551Recruiting
Omega-3 for depression in young people
This trial tests if omega-3 fatty acid supplements can improve depression in young people by reducing inflammation and changing gut bacteria. You may be eligible if you are a young person with a current major depressive episode.
Taichung, TaichungAges 13–18 - NCT07364331Recruiting
Omega-3 supplements for ADHD symptoms
This trial tests whether omega-3 fatty acids can improve attention and hyperactivity in people with ADHD. It compares omega-3 treatment against a placebo to see if it helps reduce symptoms.
TaichungAges 6–18 - NCT07364565Recruiting
Green tea mouthwash for plaque and gum health
This trial tests whether a pure green tea mouthwash can reduce plaque and gum inflammation better than a placebo or an essential oils mouthwash. It may be a good option if you have healthy gums and are looking for a natural alternative.
Irbid, Irbid GovernorateAges 18 years+ - NCT07365332RecruitingPhase 3
IKT-001 for pulmonary arterial hypertension
This study tests a new medicine called IKT-001 for people with pulmonary arterial hypertension (PAH). It aims to see if IKT-001 helps improve exercise ability and other symptoms when added to current PAH therapies.
Louisville, KentuckyAges 18–75 - NCT07365462RecruitingPhase 2
Study of NBI-1065890 for tardive dyskinesia in adults
This trial tests whether an oral medication, NBI-1065890, can reduce the involuntary muscle movements caused by long-term use of antipsychotic drugs. It is for adults with moderate to severe tardive dyskinesia who also have a stable mental health condition like schizophrenia or bipolar disorder.
Bryant, ArkansasAges 18–75 - NCT07366866RecruitingPhase 1
Safety study of an experimental drug in healthy adults
This trial tests a new drug, GenSci136, in healthy adults to see if it's safe and how the body processes it. If you qualify, you would receive the drug and be monitored for side effects.
Shanghai, Shanghai MunicipalityAges 18–45 - NCT07367672Recruiting
How beliefs affect pain empathy
This trial studies how our expectations can change how we feel pain for others. It may help us understand the placebo effect better.
Chengdu, SichuanAges 18–30 - NCT07367724RecruitingPhase 2
Ademetionine for obstructive hypertrophic cardiomyopathy
This trial tests a medication called Ademetionine for people with obstructive hypertrophic cardiomyopathy (a condition where the heart muscle is thick and blocks blood flow). It aims to see if the drug can help improve symptoms and exercise ability.
BeijingAges 18 years+ - NCT07368062Recruiting
Mental health after a heart rhythm drug in the ICU
This study looks at the long-term mental health of people who received a drug called dexmedetomidine during an electrical storm (a dangerous heart rhythm) in the ICU.
Ottawa, OntarioAges Any age - NCT07368959RecruitingPhase 3
New treatment for corneal swelling needing surgery
This trial tests a new treatment for people with corneal swelling that needs surgery. It helps replace the inner layer of the cornea to improve vision.
Mesa, ArizonaAges 18 years+
Hear when a new Placebo - Control trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for placebo - control?
- Yes. Clin2 currently lists 3,948 recruiting placebo - control studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a placebo - control trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a placebo - control trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.